Home
Live Updates
FL118, Drug Candidate Discovered at Roswell Park, Granted FDA Orphan Drug Status for Pancreatic Cancer : comparemela.com
FL118, Drug Candidate Discovered at Roswell Park, Granted FDA Orphan Drug Status for Pancreatic Cancer
The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park
Related Keywords
United States ,
New York ,
China ,
American ,
Chinese ,
Roswell Park ,
Fengzhi Li ,
Roswell Park Care Network ,
Department Of Pharmacology ,
National Cancer ,
Canget Biotekpharma ,
American Chemical Society Journal Of Medicinal Chemistry ,
Roswell Park Comprehensive Cancer Center ,
Drug Administration ,
Orphan Drug Designation ,
Associate Professor ,
American Chemical Society ,
Medicinal Chemistry ,
Novel Derivative ,
Antitumor Agent Found ,
Chinese Tree Bark ,
New York State ,
National Cancer Institute Designated ,
Upstate New ,
Newswise ,
Da Orphan Drug Designation Pancreatic Cancer ,
All Journal News ,
Dancer ,
Healthcare ,
Us National Security ,
comparemela.com © 2020. All Rights Reserved.